Open AccessTrials of arsenic trioxide therapy should be envisioned for severely respiratory distress syndrome related to a cytokine storm in COVID-19 patients
Author(s) -
François Rieger
Publication year - 2020
Publication title -
japan journal of research
Language(s) - English
Resource type - Journals
ISSN - 2690-8077
DOI - 10.33425/2690-8077.1023
Subject(s) - cytokine storm , arsenic trioxide , covid-19 , medicine , intensive care medicine , acute respiratory distress , respiratory distress , arsenic , anesthesia , virology , outbreak , lung , chemistry , disease , organic chemistry , infectious disease (medical specialty)